Abbrea Capital, LLC Moderna, Inc. Transaction History

Abbrea Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$85.37 - $115.44 $102,444 - $138,528	1,200 Added 33.71%	4,760 $507,000
Q4 2023 Feb 02, 2024	BUY	$69.51 - $104.43 $88,625 - $133,148	1,275 Added 55.8%	3,560 $354,000
Q3 2023 Oct 31, 2023	SELL	$96.41 - $126.61 $1,831 - $2,405	-19 Reduced 0.82%	2,285 $236,000
Q2 2023 Aug 01, 2023	SELL	$118.5 - $160.53 $2,725 - $3,692	-23 Reduced 0.99%	2,304 $280,000
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $12,666 - $22,474	-107 Reduced 4.4%	2,327 $417,000
Q4 2021 Feb 04, 2022	BUY	$225.82 - $368.51 $4,290 - $7,001	19 Added 0.79%	2,434 $618,000
Q3 2021 Nov 04, 2021	SELL	$221.9 - $484.47 $110,950 - $242,235	-500 Reduced 17.15%	2,415 $929,000
Q2 2021 Aug 04, 2021	SELL	$129.91 - $234.98 $12,991 - $23,498	-100 Reduced 3.32%	2,915 $685,000
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $329,177 - $560,729	3,015 New	3,015 $395,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Abbrea Capital, LLC with notifications on news.